Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Enhabit, Inc ( (EHAB) ) is now available.
On May 15, 2026, Enhabit, Inc., a leading U.S. home health and hospice provider with a national network of in‑home care locations, was acquired by middle‑market private equity firm Kinderhook Industries for $13.80 per share in cash. As a result of the transaction, Enhabit has transitioned from a publicly traded company on the New York Stock Exchange to a privately held operator focused on expanding access to home-based clinical care.
In connection with the closing, Enhabit amended its credit facilities to add $105 million in incremental term loans and $40 million of additional revolving commitments, bringing total term debt to $420 million and revolving capacity to $200 million and making the merger subsidiary an authorized borrower. All outstanding Enhabit common shares were cancelled and converted into cash consideration, equity awards were cashed out or cancelled according to their terms, the prior board resigned and was replaced by Kinderhook’s designees, and the company moved to delist and deregister its stock, ending its SEC reporting obligations.
On May 15, 2026, Enhabit, Inc., a leading U.S. home health and hospice provider with a national network of in‑home care locations, was acquired by middle‑market private equity firm Kinderhook Industries for $13.80 per share in cash. As a result of the transaction, Enhabit has transitioned from a publicly traded company on the New York Stock Exchange to a privately held operator focused on expanding access to home-based clinical care.
In connection with the closing, Enhabit amended its credit facilities to add $105 million in incremental term loans and $40 million of additional revolving commitments, bringing total term debt to $420 million and revolving capacity to $200 million and making the merger subsidiary an authorized borrower. All outstanding Enhabit common shares were cancelled and converted into cash consideration, equity awards were cashed out or cancelled according to their terms, the prior board resigned and was replaced by Kinderhook’s designees, and the company moved to delist and deregister its stock, ending its SEC reporting obligations.
The most recent analyst rating on (EHAB) stock is a Hold with a $13.80 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
EHAB scores in the mid-range primarily due to improving financial performance (strong revenue rebound, positive EBIT, solid free cash flow, and lower leverage), supported by a constructive technical trend. The score is capped by still-slightly negative net profitability and meaningful gross margin compression, with corporate-event risk from merger-related litigation despite progress toward deal completion.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit, Inc. operates in the home health and hospice care industry, providing in‑home clinical services to patients and families across the U.S. The company has a nationwide footprint of 251 home health locations and 117 hospice locations in 35 states, leveraging technology and specialized clinical teams to deliver and coordinate high-quality care in the home setting.
Kinderhook Industries, LLC is a middle-market private equity firm with more than $11 billion of committed capital and over 500 investments and follow-on deals since inception. The firm targets growth-oriented businesses with defensible niche positions, focusing on healthcare services, environmental and industrial services, and light manufacturing and automotive sectors.
Enhabit, Inc. operates in the home health and hospice care industry, providing in‑home clinical services to patients and families across the U.S. The company has a nationwide footprint of 251 home health locations and 117 hospice locations in 35 states, leveraging technology and specialized clinical teams to deliver and coordinate high-quality care in the home setting.
Kinderhook Industries, LLC is a middle-market private equity firm with more than $11 billion of committed capital and over 500 investments and follow-on deals since inception. The firm targets growth-oriented businesses with defensible niche positions, focusing on healthcare services, environmental and industrial services, and light manufacturing and automotive sectors.
Average Trading Volume: 1,651,867
Technical Sentiment Signal: Buy
Current Market Cap: $706.9M
Find detailed analytics on EHAB stock on TipRanks’ Stock Analysis page.

